top of page
Hydrocolloid Dressing

NDC 84991-0316-1

Protect Wounds

Promote Healing

Reduce Scarring

ALUROderm   Scar Patch

Hydrocolloid Wound Care w/ Added Skin Protectants:

Allantoin 0.75%

Hyaluronic Acid

Taxifolin

ALUROderm™  Medicated Hydrocolloid Wound Dressing

For Professional Use Only

NDC 84991-0316-1

Enhance your hydrocolloid wound care with ALUROderm™  Scar Patch - the only wound dressing that combines hydrocolloid technology with Allantoin 0.75%, Hyaluronic Acid, and Taxifolin. Designed for healthcare professionals seeking versatile occlusive wound care with added skin protectants for enhanced tissue support and reduced scar formation. Flexible, comfortable, and water-resistant, our 4"x4" dressing is the ideal choice for various low-to-mildly exuding wounds types.

ALUROderm Unit Box
ALUROderm Pouch

Hydrocolloid Care

Allantoin 0.75%

Hyaluronic Acid

Taxifolin

Optimized Healing Environment

The occlusive nature of hydrocolloids creates and maintains an optimally moist healing environment - ideal for rehydrating healing tissues and promoting autolytic debridement.

Built-In Exudate Management

The hydrophilic carboxymethylcellulose (CMC) interior actively absorbs exudate away from wounds and reduces the risk of maceration to surrounding tissues.

Occlusive Wound Protection 

Waterproof polyurethane exterior forms a protective barrier around the wound, shielding it from physical stress, excess moisture, debris, foreign contaminants, and infection. 

Flexible, Moldable, & Comfortable Application

With a flexible design and durable adhesive, hydrocolloids are able to comfortably conform to various bodily regions.

Gentle Removal & Replacement

Because the hydrocolloid interior does not adhere to the wound itself, removal is gentle and pain-free - even on sensitive areas and painful wounds.

Hydrocolloid Dressing

Hydrophilic Carboxymethylcellulose Interior 

Flexible, Durable Polyurethane Exterior

Benefits of Hydrocolloid Wound Care

Designed to Support Your Body's Natural Healing Processes

24/7 Protection For Long-Wear

Hydrocolloid dressings can be worn for up to seven days at a time depending on levels of exudate. Less frequent dressing changes means less disruption to the wound healing process and improved recovery outcomes.

Flexible

Comfortable

Durable

24/7 Protection

What Makes ALUROderm   Unique?

Three Added Skin Protectants for Enhanced Regenerative Support

With so many hydrocolloid dressing options to choose from, ALUROderm™ stands alone as the only option with added active & inactive ingredients to further support healthy tissue repair and reduced scar formation.

Hyaluronic Acid

(Inactive Ingredient)

A natural polysaccharide used extensively in dermatology for its healing properties.

Efficiently retains moisture to keep skin hydrated and pliable

Contributes to healthy tissue remodeling by impacting cellular migration and proliferation

Possesses angiogenic properties - supporting new blood vessel formation in healing tissues

Allantoin 0.75%

(Active Ingredient)

Commonly utilized in topical scar-gel formulations for its various benefits.

Soothes and protects irritated skin

Promotes a hydrated environment that encourages healthy skin repair and regeneration

Stimulates fibroblastic proliferation and extracellular matrix synthesis - critical steps in wound healing

Can help minimize the appearance of scars over time by improving
pigmentation and pliability

Taxifolin

(Inactive Ingredient)

A natural flavonoid that exhibits various beneficial cytoprotective properties.

Powerful antioxidant that neutralizes free radicals and reduces oxidative stress

Improves skin elasticity and other age-related biophysical markers

Supports healthy tissue healing by reducing pro-inflammatory signaling

Surgery Centers

Orthopedists

Dermatologists

Podiatrists

Indications / Usage for ALUROderm   Scar Patch 

Supporting the Unique Needs of Various Care Settings and Wound Types

Hydrocolloid dressings are indicated for use as either a primary or secondary dressing in the treatment of non-infected, lightly to moderately exuding partial-thickness wounds.         Uses may include:

Chronic Ulcerative Conditions

Bed Sores & Pressure Ulcers

Superficial Abrasions & Blisters

Small Minor Burns

Surgical Incision Wounds

Skin Graft Donor Sites

Contraindications for use include: clinically infected wounds, heavily exuding wounds, burns beyond superficial thickness, dry wounds, wounds with exposed tendons/bone, deep punctures, tunneling wounds, & more. 

ALUROderm Unit Box
ALUROderm Pouch
Hydrocolloid Dressing

NDC 84991-0316-1

For Professional Use Only

Urgent Cares

Physicians Assistants

Nurse Practitioners

Specialty Care

Contact Us

Learn How ALUROderm™ Can Benefit Your Practice

Thanks for submitting!

References

References:

1.

King, I. C., & Sorooshian, P. (2020). Hyaluronan in skin wound healing: Therapeutic applications. Journal of Wound Care, 29(12), 782–787. https://doi.org/10.12968/jowc.2020.29.12.782

2.

Park, D., et al. (2012). Hyaluronic acid promotes angiogenesis by inducing RHAMM–TGFβ receptor interaction via CD44–PKCδ. Molecular Cells, 33(6), 563–574. https://doi.org/10.1007/s10059-012-2294-1

3.

Araújo, L. U., et al. (2010). Profile of wound healing process induced by allantoin. Acta Cirurgica Brasileira, 25(5), 460–466. https://doi.org/10.1590/S0102-86502010000500014

4.

Prager, W., & Gauglitz, G. G. (2018). Effectiveness and safety of an overnight patch containing Allium cepa extract and allantoin for post-dermatologic surgery scars. Aesthetic Plastic Surgery, 42(4), 1144–1150. https://doi.org/10.1007/s00266-018-1172-4

5.

Liu, Y., et al. (2023). An insight into novel therapeutic potentials of taxifolin. Frontiers in Pharmacology, 14, 1173855. https://doi.org/10.3389/fphar.2023.1173855

6.

Micek, I., et al. (2021). Taxifolin as a promising ingredient of cosmetics for adult skin. Antioxidants, 10(10), 1625. https://doi.org/10.3390/antiox10101625

7.

Thomas, S. (2008). Hydrocolloid dressings in the management of acute wounds: A review of the literature. International Wound Journal, 5(5), 602–613. https://doi.org/10.1111/j.1742-481X.2008.00541.x

8.

Weller, C. D., Team, V., & Sussman, G. (2020). First-line interactive wound dressing update: A comprehensive review of the evidence. Frontiers in Pharmacology, 11, 155. https://doi.org/10.3389/fphar.2020.00155

Olakino Therapeutics, LLC

Honolulu, HI 96813

Olakinoâ„¢ Therapeutics 2025

bottom of page